In the future, if kallistatin is administered to cardiac arrest survivors, cardiac arrest animal models, and ischemic reperfusion damage of neuronal cells, the relationship between kallistatin and neuronal oxidation damage can be more clearly identified and used as predictive indicators of treatment and neurological outcome. Here, SERPINA4 is linked to cardiac arrest.